US 12419958
Clinical formulations
granted A61KA61K31/7004A61K31/728
Quick answer
US patent 12419958 (Clinical formulations) held by Astellas Institute for Regenerative Medicine expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Astellas Institute for Regenerative Medicine
- Grant date
- Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/7004, A61K31/728, A61K33/06, A61K33/14